Longevity Health Holdings, Inc.
XAGE
$0.1642
$0.00422.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -14.63% | 66.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.63% | 66.67% | |||
| Cost of Revenue | -75.00% | 1,500.00% | |||
| Gross Profit | 3.82% | 30.83% | |||
| SG&A Expenses | -24.87% | 0.91% | |||
| Depreciation & Amortization | 2.22% | -23.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.88% | 19.65% | |||
| Operating Income | 29.08% | -19.16% | |||
| Income Before Tax | 64.86% | 12.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 68.24% | 12.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.24% | 12.89% | |||
| EBIT | 29.08% | -19.16% | |||
| EBITDA | 29.49% | -20.02% | |||
| EPS Basic | 68.26% | 13.61% | |||
| Normalized Basic EPS | 64.34% | 14.96% | |||
| EPS Diluted | 68.26% | 13.61% | |||
| Normalized Diluted EPS | 64.34% | 14.96% | |||
| Average Basic Shares Outstanding | -0.02% | 0.82% | |||
| Average Diluted Shares Outstanding | -0.02% | 0.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||